PMC:7228307 / 21442-21737
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 405 | 35-39 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T233 | 231-234 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T234 | 289-294 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T429 | 35-37 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T430 | 289-294 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T103 | 40-48 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
| T104 | 171-179 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
| T105 | 280-288 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T132 | 143-150 | http://purl.obolibrary.org/obo/BFO_0000019 | denotes | quality |
| T133 | 289-294 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 405 | 35-39 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T132 | 0-295 | Sentence | denotes | To understand the immunobiology of FcγR effector responses particularly in the therapeutic mAb context, it is important to appreciate that the quality and potency of such effector responses is greatly affected by the nature of the IgG immune complex and/or the state of potential effector cells. |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T232 | 231-234 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T233 | 289-294 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T132 | 0-295 | Sentence | denotes | To understand the immunobiology of FcγR effector responses particularly in the therapeutic mAb context, it is important to appreciate that the quality and potency of such effector responses is greatly affected by the nature of the IgG immune complex and/or the state of potential effector cells. |